Sickle cell hope: drug combo raises hemoglobin in early trial
Disease control
Completed
This study tested whether adding erythropoietin (EPO) to the standard drug hydroxyurea can safely raise hemoglobin levels in adults with sickle cell disease. Seventeen participants with chronic anemia took both drugs for 12 weeks. The main goal was to see if at least a 1.0 g/dL i…
Phase: PHASE1, PHASE2 • Sponsor: Julia Xu • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC